ArticleRecent patents on anti-cancer drug discovery2024

Targeted Regulation of Osteoblasts and Osteoclasts in Osteosarcoma Patients by CSF3R Receptor Inhibition of Osteolysis Caused by Tumor Inflammation Based on Transcriptional Spectrum Analysis and Drug Library Screening.

Wei Duan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.